Ponya Therapeutics Announces New Ownership Following Strategic Acquisition

January 26, 2026

Reinforcing Commitment to Quality, Compliance, and the Future of Regenerative Medicine

(Isstories Editorial):- Atlanta, Georgia Jan 26, 2026 (Issuewire.com) – Ponya Therapeutics officially announced today the completion of a strategic acquisition earlier this year, ushering in new ownership with a clear, focused commitment to elevating quality, regulatory compliance, and scientific integrity across every aspect of the organization.

More on Isstories:

With this transition, Ponya Therapeutics is reaffirming its mission to advance the field of regenerative medicine by delivering high-quality tissue allografts that align with regulatory standards and support the evolving needs of healthcare professionals nationwide. The new leadership team brings a quality-first mindset rooted in operational excellence, rigorous oversight, and a long-term vision for responsible growth in regenerative medicine.

Our goal is simple but powerful. We want to ensure that doctors have access to tissue allograft products that are handled with the highest standards of care, safety, and compliance – so they can make informed decisions for their patients.

Expanding Access Through Awareness

As part of its growth strategy, Ponya Therapeutics is launching a national outreach initiative to approach 1,000 new medical practices to evaluate the benefits of working with Ponya Therapeutics using our cash products. This effort is centered on education, awareness, and access – driven by the belief that patients across America should have regenerative options available to them through qualified healthcare professionals.

By increasing awareness and availability, Ponya Therapeutics aims to support doctors in exploring compliant regenerative solutions while helping expand responsible access throughout the United States.

We believe regenerative options should be part of the conversation in modern medicine. This initiative is about education, evaluation, and choice – for providers and for patients.

With new ownership in place and a renewed commitment to excellence, Ponya Therapeutics is positioning itself for thoughtful expansion – guided by compliance, transparency, and scientific responsibility. The company remains dedicated to supporting doctors while contributing to the broader awareness and availability of regenerative options in the U.S.

For more information about Ponya Therapeutics, visit https://ponyatx.com.

About Ponya Therapeutics
Ponya Therapeutics is a regenerative medicine company focused on providing high-quality HCT/P tissue allografts to healthcare professionals. The company is committed to innovation, safety, and scientific integrity, with a mission to support compliant regenerative options for patients nationwide.